Skip to main content
. 2023 Jun 20;9(2):45–52. doi: 10.1016/j.afos.2023.06.001

Table 12.

Recommendations for raloxifene therapy.

Recommendations Grading of recommendations Quality of evidence
Postmenopausal osteoporosis with l-spine T-score ≤ −2.5 and no risk of other fracturesa IIa A
Alternative treatment for postmenopausal women at high fracture risk who are not appropriate to use bisphosphonate and denosumab IIa A
Prevention of bone loss in postmenopausal women with risk factor(s) for osteoporosis and breast cancer IIa A
a

For reduction of vertebral fracture.